STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2021 Earnings Conference Call August 16, 2021 4:30 PM ET Company Participants Leigh Salvo - Gilmartin Group Robert Moccia - President, CEO & Director Matthew Hill - VP & CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Suraj Kalia - Oppenheimer Operator Good day, and welcome to the STRATA Skin Sciences' Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. Please note, this conference is being recorded. I would now like to ...

Start Time: 16:30 January 1, 0000 5:08 PM ET STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2021 Earnings Conference Call May 12, 2021, 16:30 PM ET Company Participants Robert Moccia - CEO Matthew Hill - CFO Leigh Salvo - IR Conference Call Participants Joseph Pantginis - H.C. Wainwright Jeffrey Cohen - Ladenburg Thalmann Suraj Kalia - Oppenheimer Operator Greetings, and welcome to STRATA Skin Sciences First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A ques ...

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2020 Earnings Conference Call March 24, 2021 4:30 PM ET Company Participants Leigh Salvo - IR Robert Moccia - President, CEO & Director Matthew Hill - VP & CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Suraj Kalia - Oppenheimer Operator Greetings, and welcome to STRATA Skin Sciences Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Leigh Salvo. You may begin. Leigh S ...

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q3 2020 Results Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Leigh Salvo - Investor Relations Dolev Rafaeli - President and Chief Executive Officer Matt Hill - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Suraj Kalia - Oppenheimer & Company Operator Greetings, and welcome to STRATA Skin SciencesÂ' Third Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference ...

| --- | --- | --- | --- | --- | |-------|---------------------------------------|---------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | S e p t e m b e r 2 0 2 0 | | | | | | | | | | | Driving Value to Dermatology Partners | | | | | | | | | | | | | | | | | | | | | | Safe Harbor Statement This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors. A ...

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2020 Earnings Conference Call August 11, 2020 8:30 AM ET Company Participants Monique Kosse – LifeSci Advisors Dolev Rafaeli – President and Chief Executive Officer Matt Hill – Chief Financial Officer Conference Call Participants Suraj Kalia – Oppenheimer Jeffrey Cohen – Ladenburg Thalmann Shawn Boyd – Next Mark Capital Operator Greetings, and welcome to STRATA Skin SciencesÂ' Second Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, thi ...

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2020 Earnings Conference Call May 12, 2020 8:30 AM ET Company Participants Matthew Picciano – Managing Director of LifeSci Advisors Dr. Dolev Rafaeli – President and Chief Executive Officer Matt Hill – Chief Financial Officer Conference Call Participants Destiny Buch – Ladenburg Thalmann Jo Pantginis – H.C. Wainwright Suraj Kalia – Oppenheimer Operator Greetings, and welcome to the STRATA Skin Sciences First Quarter 2020 Earnings Conference Call. [Operator Instruc ...

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2019 Earnings Conference Call March 17, 2020 8:00 AM ET Company Participants Matt Picciano - LifeSci Advisors Dolev Rafaeli - President & Chief Executive Officer Matt Hill - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Joe Pantginis - H.C. Wainwright Suraj Kalia - Oppenheimer Shawn Boyd - Next Mark Capital Operator Greetings, and welcome to the STRATA Skin Sciences Fourth Quarter and Fiscal Year 2019 Earnings Call. At thi ...

行业和公司概述: 1. 该公司是一家专注于皮肤科医疗设备的上市公司,主要产品是XTRAC 308纳米准分子激光系统 [1] 2. 公司在美国国内市场拥有约784台XTRAC设备,是该领域的主要参与者,与另一家竞争对手分享市场 [27] 3. 公司在韩国、日本等海外市场也有数百台XTRAC设备安装,是当地的行业标准 [15][16] 核心观点和论据: 1. 公司在2018年完成了财务重组,改善了资产负债表,为未来发展奠定了基础 [9] 2. 公司加大了对直接面向消费者(DTC)广告的投入,带动了新患者的增加,每年新增患者数量增长29% [10][11] 3. 公司通过"comeback"策略,将非生产性设备更换为新的生产性设备,提升了毛利率 [12] 4. 公司与私募股权支持的连锁皮肤科诊所合作,大幅增加了设备安装量 [13] 5. 公司在韩国和日本等海外市场推出了新的设备置换模式,未来将带来更多的经常性收入 [14][16] 6. 公司在技术方面也有所突破,推出了新一代XTRAC S3设备和多微剂量(MMD)技术,提升了治疗效果 [17][18] 其他重要内容: 1. 公司2018年全年净亏损400万美元,较2017年的2150万美元大幅改善 [28] 2. 公司2019年第三季度末现金余额超1600万美元,财务状况良好 [29] 3. 公司需要重新报告2017-2019年的财务数据,主要涉及一些非现金会计调整,但不影响基本业务 [21]-[25]